Both offer 3-in-1 combination ED formulas — but with fundamentally different third ingredients, delivery formats, and onset times.
| Attribute | Rugiet Ready | Hims 3-in-1 |
|---|---|---|
| Formula | 3-in-1 | 3-in-1 |
| Sildenafil | ✓ | ✓ |
| Tadalafil | ✓ | ✓ |
| Third ingredient | Apomorphine (dopamine agonist) | Oxytocin (bonding hormone) |
| Format | Sublingual lozenge | Pill or chewable (patient choice) |
| Onset | ~15 minutes | 30–60 minutes |
| Duration | Up to 36 hours | Up to 36 hours |
| Dosing tiers | 4 tiers (Low–Maximum) | Varies by plan |
| Price | 15% off w/ ET2026 | Varies by plan |
| User base | 300,000+ users | Large mainstream platform |
| Best for | Psychological + vascular ED, spontaneity | Relational/emotional ED, format flexibility |
Apomorphine is a dopamine D1/D2 receptor agonist — it acts on the brain's arousal circuitry to enhance sexual desire and lower the threshold for arousal. It targets the neurological component of ED: the upstream signal that needs to fire before blood flow mechanisms can work.
Oxytocin is the bonding hormone — released during physical touch, intimacy, and orgasm. It targets the relational and emotional dimension: the sense of connection with a partner that makes arousal feel natural rather than pressured. It reduces social anxiety and supports pro-social bonding.
Rugiet's sublingual lozenge absorbs through the mucous membranes under the tongue — onset in approximately 15 minutes. Hims uses a standard pill or chewable tablet that passes through the digestive system — onset 30–60 minutes.
For men who prioritize spontaneity, this 15–45 minute difference in onset is meaningful. Rugiet wins clearly on speed. Hims wins on format flexibility — the option to choose between pill and chewable is something no other provider in this comparison offers.